The John S. Latsis Public Benefit Foundation, in cooperation with the A. G. Leventis Foundation and Onassis Foundation, have taken part as funders in a programme designed and run by the Bodossaki Foundation, with regard to financing the costs of patent registrations for researchers and research teams
in Greek research centres and universities.
The aim of the Programme is to support and promote the high-quality innovative research conducted by universities and public research centres in Greece, as well as to strengthen the Greek economy through the creation and support of innovative businesses that will produce exportable products and services based on the results of the research in question. The Programme’s public call was addressed to Greek researchers and research teams working or operating within Higher Education Institutions (Universities and Technical Educational Institutes - T.E.I.) and public Research Centres in Greece.
The Programme provides funding for the preparation and submission of a Patent application, as well as the registration of copyright and industrial property rights in Greece and/or abroad. At the same time, through the collaboration of organisations providing support services to new businesses, the selected researchers and research teams receive further assistance and guidance in their first business steps, free of charge.
Researchers and research teams from the Biomedical Research Foundation of the Academy of Athens (BRFAA), the National Centre of Scientific Research “Demokritos”, the Foundation for Research & Technology, the University of West Attica, the National Technical University of Athens, the Athens University of Economics and Business and the Institute of Communication and Computer Systems (ICCS) participate in the Programme.
8 research proposals in the scientific fields of Medicine, Physics/Biomedicine, Nanotechnology, Informatics, Energy Technology and Biotechnology were approved following evaluation by the Selection Committee.
“The Programme made a great contribution and supported our know-how in laser bioprinting with the aim of enabling precise biomaterial printing, tissue engineering and the use of regenerative medicine applications. Through the programme’s support, we managed to found ‘PhosPrint’, an ICCS/NTUA spin-off company –this patent is the main intellectual property of the company–, as well as to achieve our team’s research goals, by securing our copyright and being able to make the best use of our technology.”
Professor, School of Applied Mathematics and Physical Sciences, National Technical University of Athens
Researcher, Institute of Communication and Computer Systems